Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19
Condition(s):Corona Virus Infection; COVID-19Last Updated:July 2, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Corona Virus Infection; COVID-19Last Updated:July 2, 2020Unknown status
Condition(s):Anemia in Dialysis-dependent CKD PatientsLast Updated:February 1, 2024Recruiting
Condition(s):Kidney FailureLast Updated:October 22, 2012Completed
Condition(s):Pneumonia; Neurological DysphagiaLast Updated:February 9, 2015Terminated
Condition(s):Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Infarction; Myocardial IschemiaLast Updated:April 15, 2016Completed
Condition(s):COVID-19Last Updated:August 4, 2020Completed
Condition(s):Radiographic Contrast Agent NephropathyLast Updated:June 8, 2015Completed
Condition(s):Congenital Heart DiseaseLast Updated:July 26, 2017Completed
Condition(s):Renal Insufficiency, ChronicLast Updated:June 20, 2012Unknown status
Condition(s):Brain Infarction; HypertensionLast Updated:October 30, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.